Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever
Abstract: 105 cases of Epidemic Hemorrhagic Fever (EHF) were randomly divided into 2 groups, 62 cases were treated with ribavirin and 43 cases served as control. The study group received ribavirin 700-800mg/day iv infusion for 3 days, while the control group was treated with symptomatic therapy only. In the study group fever lowered and albuminuria disappeared more rapidly, other clinical symptoms were recovered much quicker and specific circulating immune complexes persisted shorter. These results showed that ribavi...